Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

7,260 total articles

Buy the Dip After a Miss: TransMedics Still a Growth Story

Buy the Dip After a Miss: TransMedics Still a Growth Story

TransMedics (TMDX) sold off after a recent earnings surprise, but the company's core organ-care franchise continues to produce strong unit growth, solid free cash flow and attractive valuation ratios versus future growth. This trade idea proposes a tactical long into the weakness with a clear entry, stop and target and a mid-term horizon to let the…

Canada Nickel: Catalyst-Rich Setup for a Tactical Long

Canada Nickel: Catalyst-Rich Setup for a Tactical Long

Canada Nickel offers a high-beta play on nickel exposure with a dense calendar of de-risking milestones. For disciplined traders, a long exposure using tight risk controls captures near-term upside from technical re-ratings and longer-term optionality if project execution and permitting stay on track.

ServiceNow: A Conviction Long as the Turnaround Narrative Gains Traction

ServiceNow: A Conviction Long as the Turnaround Narrative Gains Traction

ServiceNow has been punished this year amid growth and margin worries, but recent guidance and early signs of AI product monetization make a defined long trade attractive. Market cap near $105B, meaningful free cash flow, low net leverage and a concentrated short book create a favorable risk/reward for a mid-term bounce to $130. Trade plan, catalys…

Why Sandisk Is A Buy Despite Jumbo Multiples - A Tactical Long

Why Sandisk Is A Buy Despite Jumbo Multiples - A Tactical Long

Sandisk looks expensive at face value: $1477 stock price, a ~49x P/E and price-to-sales north of 16. But dig into margins, cash flow and the AI-driven demand curve, and the premium starts to make sense. I lay out an actionable long trade with entry at $1480.00, a $2000.00 target and $1250.00 stop, and explain the key catalysts and risks that should…

Aeluma: Positioning for an Optics Inflection as AI Traffic Grows

Aeluma: Positioning for an Optics Inflection as AI Traffic Grows

Aeluma's integrated photonics and quantum dot laser roadmap has a string of recent catalysts - a NASA award, a $4M government contract, and a senior Intel hire - that make the company a plausible beneficiary of rising AI data-center interconnect demand. The business is early, revenue is minimal, and valuation already prices a lot of future growth. …

TORM (TRMD): High Yield, Active Shareholders and a Tight Risk-Reward

TORM (TRMD): High Yield, Active Shareholders and a Tight Risk-Reward

TORM offers a rare combination for income-oriented traders: a >6% yield, activist/strategic shareholder activity and a valuation that reads cheap on simple multiples. Pair that with a recent stretch of operational outperformance and upcoming dividend flow and you have a tradeable long with clear entry, target and stop. This is a tactical position f…

Buy TMC on the Dip - Play the Critical Minerals Supply Chain Reopening

Buy TMC on the Dip - Play the Critical Minerals Supply Chain Reopening

TMC the metals company (TMC) is a high-risk, high-reward play on deep-sea polymetallic nodules that contain nickel, cobalt, copper and manganese. With a new Allseas contract, favorable regulatory momentum and a market cap of $2.34B that represents only a sliver of the company's cited NPV of its resources, now is an actionable dip to take a measured…

Buy IMVT: IMVT-1402 Is the Reason to Re-rate Immunovant Now

Buy IMVT: IMVT-1402 Is the Reason to Re-rate Immunovant Now

Immunovant (IMVT) is upgraded to Buy after recent evidence and corporate moves that increase the probability IMVT-1402 becomes a multi-indication FcRn franchise. The setup combines a crowded but expanding autoimmune market, upcoming near-term readouts (RA topline expected H2 2026) and improved technical momentum. This is a high-risk, potentially hi…

A Peer Showdown: Why Vistra Looks Best Positioned Among Big U.S. IPPs

A Peer Showdown: Why Vistra Looks Best Positioned Among Big U.S. IPPs

Vistra's combination of long-term data center contracts, solid free cash flow ($1.803B) and an EV/EBITDA of 10.9 give it tactical edge versus peers that are either more leveraged to commodity swings or slower to monetize AI-driven demand. This trade idea targets a mid-term swing capturing re-rating potential while keeping a tight stop for leverage …

Buy SCZ on the Pullback - A Cleaner Risk/Reward for EAFE Small-Caps

Buy SCZ on the Pullback - A Cleaner Risk/Reward for EAFE Small-Caps

SCZ, the iShares MSCI EAFE Small-Cap ETF, dipped recently but key technicals and yield profile make the risk/reward attractive. Market-cap $14.6B, a 2.6% dividend yield and a 30-day SEC yield of 2.04% help lower carry-adjusted downside while price sits near support. We lay out a mid-term (45 trading days) trade plan with entry, stop and target alon…